Fierce JPM Week - Virtual Agenda has ended
Back To Schedule
Wednesday, January 19 • 10:15am - 10:30am
Improve clinical oncology drug development with diligent planning, unique trial design and deep data analysis

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Join Dr. Stephen Gately and Tara Franks as they discuss TD2's patient driven mission to focus cutting edge science into translational solutions for our partners.

avatar for Stephen Gately, Ph.D.

Stephen Gately, Ph.D.

President and CEO, TD2
Dr. Stephen Gately obtained his Ph.D. from McGill University in the Department of Neurology and Neurosurgery at the Montreal Neurological Institute and Hospital. Thereafter he joined the Department of Medicine, Division of Hematology/Oncology at Northwestern University Feinberg School... Read More →
avatar for Tara Franks

Tara Franks

Chief Operating Officer, TD2
Tara Franks is currently Chief Operating Officer at TD2 and leads business development, administrative, operational and financial activities. She is also responsible for managing strategic business initiatives and collaborations. She has more than a decade of experience in business... Read More →

Wednesday January 19, 2022 10:15am - 10:30am EST